Managing Adverse Events and Supportive Care Measures in CLL Treatment

Video content above is prompted by the following:

• What proactive strategies and interventions are used to manage adverse events before resorting to dose modification?
• What supportive care measures are typically implemented to manage adverse events in chronic lymphocytic leukemia treatments and do these vary based on the specific Bruton tyrosine kinase inhibitor?